2023 annual financial data
Rani Therapeutics Holdings 2023 Net income growth
Direct answer
Net income growth was -11.06%.
Operating income was -66,099,000 USD and net income was -33,970,000 USD.
Operating cash flow was -51,236,000 USD.
Get free Rani Therapeutics Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -66,099,000 USD
- Net income
- -33,970,000 USD
- Operating cash flow
- -51,236,000 USD